This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Longuide Biopharma Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Meigui Liang: Innovator in Lipid Nanoparticle Formulations
Introduction
Meigui Liang is a prominent inventor based in Shenzhen, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of lipid nanoparticle formulations. His work focuses on innovative methods for delivering nucleic acids, such as mRNA, which are crucial for various therapeutic applications.
Latest Patents
Meigui Liang holds a patent for "Lipids and lipid nanoparticle formulations." This patent relates to lipids and lipid nanoparticle formulations, as well as methods for using these formulations to deliver nucleic acids effectively. His innovative approach has the potential to enhance the efficacy of mRNA delivery systems.
Career Highlights
Liang is currently employed at Longuide Biopharma Corporation, where he continues to advance research in lipid formulations. His expertise in this area has positioned him as a key player in the biopharmaceutical industry. With 1 patent to his name, he is recognized for his contributions to the field.
Collaborations
Meigui Liang collaborates with notable colleagues, including Longgui Zhang and Yuebao Zhang. Their combined efforts contribute to the ongoing research and development initiatives at Longuide Biopharma Corporation.
Conclusion
Meigui Liang's work in lipid nanoparticle formulations represents a significant advancement in the delivery of nucleic acids. His innovative contributions are paving the way for future developments in biopharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile